Analyst
Calyon Securities
Equibles does not estimate personal net worth.
Paul Kuhn is recorded as Analyst at Calyon Securities. Paul Kuhn has spoken on 1 earnings call across 1 company, most recently for Roche Holding AG on January 29, 2026. The companies whose calls Paul Kuhn spoke on are classified in the Healthcare sector.
“What feedback have you heard from U.S. oncologists and how they plan to initially use giridestrant in the adjuvant setting? And secondly, how did the change in Zolaire biosimilar entry from end of 2026 to before November 2026 come about?”
Calyon Securities
Analyst
Transcript header (unverified)
Roche Holding AG
Drug Manufacturers - General · Healthcare
Roche has published its Full Year Results for 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 29 January 2026.
Roche Holding AG
